Introduction
This information will help you understand your choices,
whether you share in the decision-making process or rely on your doctor's
recommendation.
Key points in making your decision
Anticoagulant
medicine, such as warfarin (Coumadin, for example), is highly effective in
preventing
stroke and death due to stroke in people with
atrial fibrillation. But it may not be suitable for
everyone. Consider the following when making your decision:
- Anticoagulant medicine, such as warfarin, provides the best protection against stroke,
if you can take it.
- Almost everyone who has atrial fibrillation
should take warfarin. The only people with atrial fibrillation who may not
benefit from taking warfarin are people with lone atrial fibrillation who are
younger than 65 and have no other risk factors for stroke, or people with
chronic kidney disease, recent surgery or head trauma,
a history of gastrointestinal bleeding, or alcoholism.
- If you are
going to have
cardioversion, your doctor will recommend that you
take anticoagulant medicine for 3 weeks before and for at least 4 weeks after
cardioversion, to reduce the risk of stroke.
- If you have lone
atrial fibrillation and are younger than 60, you can take 325 mg of aspirin
daily instead of warfarin.
- If you are at risk for a stroke, aspirin
can help prevent a stroke. But aspirin does not work as well as
warfarin.
- When taking anticoagulants, you are required to have
regular blood tests to assess your risk for problem bleeding.
Medical Information
What is an anticoagulant medicine?
Anticoagulants
are medicines that help prevent blood clots. They are often called blood
thinners, but they do not actually thin the blood. Instead, anticoagulants work
by increasing the time it takes a blood clot to form.
Why is it important to take anticoagulant medicines?
Atrial fibrillation increases your risk of
stroke. People with atrial fibrillation and an
otherwise normal heart are 5 to 6 times more likely to have a stroke than
people who do not have atrial fibrillation.1 People
who have heart valve damage along with atrial fibrillation have an even higher
risk. Taking anticoagulant medicines significantly reduces your risk. The most
commonly used anticoagulants are warfarin and heparin.
What are the risks of taking anticoagulant medicines?
Anticoagulants slow the amount of time it takes for your blood to clot.
This increases your risk of developing problems with bleeding within and around
the brain, bleeding in the stomach and intestines, bruising and bleeding if
injured, and serious skin rash.
You should not take
anticoagulants if you:
- Have unexplained blood in the
stool.
- Have uncontrolled high blood pressure.
- Are at
high risk for falling.
- Are unable to take the medicine as
directed.
- Drink large amounts of alcohol.
- Are unable or
unwilling to have regular blood tests.
Women with atrial fibrillation who are pregnant or plan
to become pregnant should talk with their doctor about the potential benefits
and risks of taking anticoagulants. These women should not take warfarin (such
as Coumadin) because it can cause birth defects. Use of some anticoagulants,
such as heparin, may complicate pregnancy and childbirth and can increase the
risk of developing
osteoporosis or
thrombocytopenia if taken over the long term.
How well do anticoagulants work?
Anticoagulants
significantly reduce the risk of stroke in people who have atrial
fibrillation.2 But how much your risk will be lowered
depends on how high your risk was to start with. Not everyone with atrial
fibrillation has the same risk of stroke. It's a good idea to talk with your
doctor about your risk.
You will want to weigh the benefits of
reducing your risk of stroke with the risks of taking anticoagulants. Warfarin
works well to prevent stroke. But warfarin also increases the risk of bleeding.
Each year about 2 out of 100 people who take warfarin will have a problem with
severe bleeding, and 98 will not.3 But this is an
average risk. Your own risk may be higher or lower than average based on your
own health.
What can you do instead of taking anticoagulants?
Aspirin may be a good choice if you are young and have
no other heart or health problems or if you can't take warfarin safely. Aspirin
doesn't work as well as warfarin to reduce your stroke risk. But aspirin is
less likely to cause bleeding problems.
If you are at low risk
for stroke or can't take warfarin, your doctor may recommend that you take
aspirin. Aspirin is an
antiplatelet medicine. It decreases the risk of blood
clotting by preventing the smallest blood cells (platelets) from sticking
together and making a clot.
Aspirin lowers the risk of stroke in
people with atrial fibrillation but not nearly as much as warfarin does. How
much your risk will be reduced depends on how high your risk was to start with.
Aspirin is less likely than anticoagulants to cause bleeding
problems. Bleeding that is bad enough to need treatment in a hospital happens
in 1 or 2 out of 1,000 people who take aspirin.4 This
means that 998 or 999 out of 1,000 people who take aspirin don't have serious
bleeding.
Other antiplatelet medicines, such as clopidogrel
(Plavix), may be used if you can't take aspirin.
For more information, see the topic
Atrial Fibrillation.
Your Information
Your choices are:
- Take anticoagulants to reduce the risk of
stroke.
- Do not take anticoagulants-take aspirin instead.
The decision about whether to take anticoagulants takes
into account your personal feelings and the medical facts.
Deciding about taking anticoagulants | Reasons to
take anticoagulants | Reasons not
to take anticoagulants |
- Anticoagulants significantly reduce the
risk of stroke and death from stroke.
Are there other reasons that you might want to take
anticoagulants? | - Anticoagulants have side effects,
including problem bleeding, bruising, and skin rash.
- You will need
to have frequent blood tests to check the level of the anticoagulant in your
blood.
Are there other reasons that you might not want to
take anticoagulants? |
These
personal stories may help you make your
decision.
Wise Health Decision
Use this worksheet to help you make your decision.
After completing it, you should have a better idea of how you feel about taking
anticoagulants. Discuss the worksheet with your doctor.
Circle the
answer that best applies to you.
| I am at high risk for stroke. | Yes | No | Unsure |
| I am not an alcoholic. | Yes | No | Unsure |
| I am not comfortable having frequent blood tests.
| Yes | No | Unsure |
| I am older than 60, and I don't have lone atrial
fibrillation. | Yes | No | Unsure |
| I am going to have cardioversion for atrial
fibrillation. | Yes | No | Unsure |
| I am pregnant or plan to become pregnant. | Yes | No | Unsure |
Use the following space to list any other important
concerns you have about this decision.
What is your overall impression?
Your answers in
the above worksheet are meant to give you a general idea of where you stand on
this decision. You may have one overriding reason to take or not to take
anticoagulants.
Check the box below that represents your overall
impression about your decision.
Leaning toward taking anticoagulants | | Leaning toward NOT taking anticoagulants |
Return to the topic
Atrial Fibrillation.
References
Citations
Wang TJ, et al. (2003). A risk score for predicting
stroke or death in individuals with new-onset atrial fibrillation in the
community: The Framingham heart study. JAMA, 290(8):
1049-1056.
Hart R, et al. (2007). Meta-analysis: Antithrombotic
therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.
Annals of Internal Medicine, 146: 857-867.
Antiplatelet and anticoagulant drugs (2008).
Treatment Guidelines From The Medical Letter, 6(69):
29-36.
Patrono C, et al. (2008). Antiplatelet drugs: American
College of Chest Physicians evidence-based clinical practice guidelines (8th
edition). Chest, 133(6): 199S-233S.
Wang TJ, et al. (2003). A risk score for predicting
stroke or death in individuals with new-onset atrial fibrillation in the
community: The Framingham heart study. JAMA, 290(8):
1049-1056.
Hart R, et al. (2007). Meta-analysis: Antithrombotic
therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.
Annals of Internal Medicine, 146: 857-867.
Antiplatelet and anticoagulant drugs (2008).
Treatment Guidelines From The Medical Letter, 6(69):
29-36.
Patrono C, et al. (2008). Antiplatelet drugs: American
College of Chest Physicians evidence-based clinical practice guidelines (8th
edition). Chest, 133(6): 199S-233S.